Global commercial biopharmaceutical company BeiGene is dedicated to the development of molecular targeted drugs and immuno-oncology drugs. It is a leading innovator in medicine field in China.
BeiGene Case Study with Jimmy Zhang, Partner at Lily Asia Ventures
创业讲堂 | Lecture 4
Veritas Genetics is the first whole genome sequencing company to break the $1k cost barrier for whole genome sequencing in the U.S. It has been named as one of the MIT Technology Review’s 50 Smartest Companies in 2016, 2017 and CNBC’s Disruptor 50 Companies in 2018.
Creating U.S. - China Big Data Genomics Companies, Preston Estep, Co-founder and CSO of Veritas Genetics
创业讲堂 | Lecture 7
For over 40 years, the Tufts Center for the Study of Drug Development has documented the growing challenge of bringing new pharmaceutical products to market. In today’s environment, drug developers are under increasing pressure to streamline the drug development process, reduce R&D costs, and focus on therapies with demonstrable value over existing treatments.
The Certain Uncertainty of New Drug Development, Professor Kenneth Kaitin, Director of Tufts CSDD
创业讲堂 | Lecture 10
Dr. Bing Wang, Associate Professor in Practice of Real Estate and the Built Environment, teaches design and real estate courses at the Graduate School of Design, Harvard University.
in Real Estate
with Professor Bing Wang
创业讲堂 | Lecture 2
Dr. Junfeng Wang is the founder of Nanjing Yudu Communication Co, Ltd. The company was invested and constructed by the returnee team led by Dr. Wang Junfeng of the Massachusetts Institute of Technology.
Entrepreneurship in Industry and Academia - Challenges and Opportunities, Dr. Junfeng Wang
创业讲堂 | Lecture 5
Linear Capital is a frontier technology fund management company focusing on investments in data application, data infrastructure and innovative technologies in China and the great Asia area. It has $250M AUM and invested in more than 50 companies.
From “Building Facebook” to Linear Capital, Harry Wang, CEO & Founder of Linear Capital
创业讲堂 | Lecture 8
Andrew W. Lo is the Charles E. and Susan T. Harris Professor at the MIT Sloan School of Management, director of the MIT Laboratory for Financial Engineering, a principal investigator at the MIT Computer Science and Artificial Intelligence Laboratory.
Financing Biotech and Healthcare Innovation, Professor Andrew Lo, MIT Sloan School of Management
Since its inception in 2000, Flagship Pioneering has raised more than $2.32 billion in funds, launched more than 96 portfolio companies with an aggregated valuation of $20 billion, and managed funds proven to be top performers among all VCs of the same vintage.
Flagship Pioneering Case Study with Professor Hong Luo, Associate Professor of Harvard Business School
创业讲堂 | Lecture 6
Grab is using AI and other technologies to digitalize Southeast Asia and uplifting the lives of 640 million population across 11 countries. Dubbed the "Uber of Southeast Asia", Grab is the biggest unicorn of Southeast Asia backed by SoftBank, Toyota, Honda, Uber, and Didi, to name a few.
Mark Porter, from a NASA Engineer to Grab CTO
创业讲堂 | Lecture 9
Having spent roughly 10 years in academia as a tenured professor, 7 years in a big company, and 15 years as CTO/CEO in life science startups, Dr. Natan has a unique perspective on both entrepreneurship and career development.
Lessons from Navigating Entrepreneurship in Academia, Startups and Big Companies, Dr. Michael Natan, President and CEO of Ultivue, Inc.